CD274 and cancer: The fact that PD-L1 protects cancer cells from immune-mediated cell death via activation of the PI3K/AKT pathway and mTOR [108] supports the notion that dysregulated cancer cell-autonomous metabolism might represent a two-way barrier against antitumor immunity.